Melanoma Stage IIIc
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients (NCT06556004) | University of Chile | 2021-05-02 |
| Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients (NCT03567889) | Philogen S.p.A. | 2018-09-20 |
Track Melanoma Stage IIIc automatically
Every clearance here is in the API, with alerts when new ones post.